TY  - JOUR
AU  - Fernández-Avilés, Francisco
AU  - Sanz-Ruiz, Ricardo
AU  - Bogaert, Jan
AU  - Casado Plasencia, Ana
AU  - Gilaberte, Inmaculada
AU  - Belmans, Ann
AU  - Fernández-Santos, Maria Eugenia
AU  - Charron, Dominique
AU  - Mulet, Miguel
AU  - Yotti, Raquel
AU  - Palacios, Itziar
AU  - Luque, Manuel
AU  - Sádaba, Rafael
AU  - San Román, J Alberto
AU  - Larman, Mariano
AU  - Sánchez, Pedro L
AU  - Sanchís, Juan
AU  - Jiménez, Manuel F
AU  - Claus, Piet
AU  - Al-Daccak, Reem
AU  - Lombardo, Eleuterio
AU  - Abad, José Luis
AU  - DelaRosa, Olga
AU  - Corcóstegui, Lucia
AU  - Bermejo, Javier
AU  - Janssens, Stefan
PY  - 2018
DO  - 10.1161/CIRCRESAHA.118.312823
UR  - https://hdl.handle.net/10668/26968
T2  - Circulation research
AB  - Allogeneic cardiac stem cells (AlloCSC-01) have shown protective, immunoregulatory, and regenerative properties with a robust safety profile in large animal models of heart disease. To investigate the safety and feasibility of early administration of...
LA  - en
KW  - acute myocardial infarction
KW  - allogeneic stem cell therapy
KW  - cardiac stem cells
KW  - heart failure
KW  - ventricular remodeling
KW  - Aged
KW  - Female
KW  - Humans
KW  - Infusions, Intra-Arterial
KW  - Male
KW  - Middle Aged
KW  - Myoblasts, Cardiac
KW  - Myocardial Infarction
KW  - Stem Cell Transplantation
KW  - Transplantation, Homologous
KW  - Ventricular Dysfunction, Left
TI  - Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
TY  - research article
VL  - 123
ER  -